CIN Special Report: Part I, Can a Dangerous Pre-Cancer Threat Be Tamed? OneMedPlace (blog) In response to some recent successes by several companies operating in the cervical cancer space, we are issuing a two-part special report exploring pre-cervical cancer and CIN. Part I of this report is a survey of the conditions: a description of how ...
Ladies: are you taking advantage of cervical screening? OUPblog (blog) Cervical screening, which aims to detect pre-malignant cervical lesions known as cervical intraepithelial neoplasia (CIN), involves sampling cervical epithelial cells via the Papanicolaou smear test or liquid-based cytology. In England, the National ...
TRANSGENE : Reports Randomized Phase 2b Data with Its Therapeutic HPV Vaccine ... - 4-traders
TRANSGENE : Reports Randomized Phase 2b Data with Its Therapeutic HPV Vaccine ... 4-traders To move the product into phase 3 clinical trials and towards registration in CIN 2/3, it was expected, in addition to at least a doubling of the resolution rate compared to placebo (which was attained), a 60% resolution rate in the HPV16 mono-infected ...
Low numbers not a basis for cancer screening limit - TODAYonline
Low numbers not a basis for cancer screening limit TODAYonline Cervical cancer is the sixth most common cancer among Singapore women, constituting 4 per cent of all cancer deaths in women. Of the incidences of Cervical Intraepithelial Neoplasia 3, which has a cancer development potential, 1.5 per cent are found in ...
RA Registry Data Reassuring on Biologic Safety - MedPage Today
RA Registry Data Reassuring on Biologic Safety MedPage Today Note that a second study reported that treatment with anti-TNF agents in patients with a prior history of cervical intraepithelial neoplasia 3 did not result in genital cancer cases. GLASGOW -- A registry sponsored by the British Society for ...
For boys, HPV vaccine effective but costly - Ottawa Citizen
For boys, HPV vaccine effective but costly Ottawa Citizen ... prevention of anal intraepithelial neoplasia, anal cancer, and anogenital warts.? ? 80 per cent to 90 per cent of anal cancers. Except for cervical cancer, which strikes 1356 women each year, 400 of whom will die, these cancers are extremely rare.
Five years later, HPV vaccination rates still ?disappointingly low? - Ottawa Citizen
Five years later, HPV vaccination rates still ?disappointingly low? Ottawa Citizen ... including those who have had abnormal Pap smears and cervical cancer. In January, 2012, NACI also recommended the vaccine for boys and men aged 9?26 ?for the prevention of anal intraepithelial neoplasia, anal cancer, and anogenital wart.
What our clients and candidates are saying about us: You are fantastic, I have recommended you to everyone I know who is look for work in this industry. - Mary
The #1 Resource for professionals in the Pharmaceutical Advertising, Medical Communications, Healthcare Public Relations, Pharmaceutical Industry, and Biotechnology fields since 1988.